Geode Capital Management LLC Acquires Shares of 443,563 Grail, Inc. (NASDAQ:GRAL)

Geode Capital Management LLC purchased a new position in shares of Grail, Inc. (NASDAQ:GRAL - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 443,563 shares of the company's stock, valued at approximately $7,920,000. Geode Capital Management LLC owned about 1.32% of Grail as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in GRAL. Crcm LP purchased a new position in Grail in the fourth quarter worth $65,061,000. Primecap Management Co. CA purchased a new position in shares of Grail in the 4th quarter valued at about $37,118,000. Vanguard Group Inc. acquired a new stake in shares of Grail in the fourth quarter valued at about $25,902,000. Bank of New York Mellon Corp acquired a new stake in shares of Grail in the fourth quarter valued at about $6,262,000. Finally, TCW Group Inc. purchased a new stake in Grail during the fourth quarter worth about $5,095,000.

Insider Buying and Selling at Grail

In other news, CEO Robert P. Ragusa sold 7,625 shares of Grail stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $31.21, for a total transaction of $237,976.25. Following the sale, the chief executive officer now owns 828,662 shares in the company, valued at $25,862,541.02. This trade represents a 0.91 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, President Joshua J. Ofman sold 2,109 shares of the company's stock in a transaction on Friday, March 7th. The shares were sold at an average price of $31.20, for a total transaction of $65,800.80. Following the completion of the transaction, the president now owns 559,673 shares of the company's stock, valued at $17,461,797.60. This trade represents a 0.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 11,550 shares of company stock worth $360,436.

Grail Trading Down 6.3 %

Shares of Grail stock traded down $2.32 during trading on Wednesday, hitting $34.49. 1,024,405 shares of the company were exchanged, compared to its average volume of 1,224,024. The firm has a 50 day moving average price of $30.48 and a 200 day moving average price of $24.73. Grail, Inc. has a fifty-two week low of $12.33 and a fifty-two week high of $63.99.

Grail (NASDAQ:GRAL - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported ($1.86) earnings per share (EPS) for the quarter, topping the consensus estimate of ($4.41) by $2.55. The firm had revenue of $38.25 million for the quarter, compared to analyst estimates of $35.33 million. Sell-side analysts anticipate that Grail, Inc. will post -15.15 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms have commented on GRAL. Canaccord Genuity Group assumed coverage on Grail in a research report on Monday, April 21st. They set a "buy" rating and a $32.00 target price on the stock. Morgan Stanley boosted their price objective on shares of Grail from $16.00 to $20.00 and gave the stock an "equal weight" rating in a research report on Tuesday, March 18th.

Grail Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.